tiprankstipranks
Advertisement
Advertisement

SE:CINPHA Stock Latest News

Cinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
Company AnnouncementsCinclus Pharma Sets May 13 Webcast for First-Quarter 2026 Report
4d ago
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
PremiumCompany Announcements
Cinclus Pharma Calls 2026 AGM, Sets Rules for Shareholder Participation
17d ago
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
PremiumCompany Announcements
Cinclus Pharma Ramps Up Investor Outreach Ahead of Late-Stage GERD Drug Push
1M ago
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
PremiumCompany Announcements
Cinclus Pharma Secures Up to EUR 28 Million to Accelerate Late-Stage Acid-Reflux Drug
2M ago
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
PremiumCompany Announcements
Cinclus Pharma Gains Boost as FDA Backs Single Pivotal Study Path for GERD Drug
2M ago
Cinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
PremiumCompany AnnouncementsCinclus Pharma Boosts 2025 Revenue but Maintains Heavy R&D-Driven Losses
2M ago
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
Premium
Company Announcements
Cinclus Pharma Wins FDA Backing for Linaprazan Glurate Nonclinical Plan
3M ago
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
Premium
Company Announcements
Cinclus Pharma Gains EMA Backing on Manufacturing Plan for GERD Drug
3M ago
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
PremiumCompany Announcements
Cinclus Pharma Sets Date for Fourth-Quarter 2025 Report and Investor Presentation
3M ago
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
PremiumCompany Announcements
Cinclus Pharma Confirms Seven-Member Board and Appoints New Director at Extraordinary Meeting
3M ago
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
PremiumCompany Announcements
Cinclus Pharma Advances Phase 3 GERD Maintenance Trial: Why Linaprazan Glurate Matters for Investors
4M ago
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
PremiumCompany Announcements
Cinclus Pharma’s Linaprazan Glurate Gains China Reimbursement Listing
5M ago
Cinclus Pharma Appoints New CFO Amidst Strategic Advancements
PremiumCompany AnnouncementsCinclus Pharma Appoints New CFO Amidst Strategic Advancements
5M ago
Cinclus Pharma Announces Extraordinary General Meeting
Premium
Company Announcements
Cinclus Pharma Announces Extraordinary General Meeting
5M ago
Cinclus Pharma Proposes New Board Member Amidst Strategic Milestone
Premium
Company Announcements
Cinclus Pharma Proposes New Board Member Amidst Strategic Milestone
5M ago
Cinclus Pharma Hosts Event on GERD Treatment Advancements
PremiumCompany Announcements
Cinclus Pharma Hosts Event on GERD Treatment Advancements
5M ago
Cinclus Pharma Reports Q3 2025 Financial Results Amidst Continued R&D Investment
PremiumCompany Announcements
Cinclus Pharma Reports Q3 2025 Financial Results Amidst Continued R&D Investment
5M ago
Cinclus Pharma Reports Increased Sales but Faces Financial Challenges in 2025
PremiumCompany Announcements
Cinclus Pharma Reports Increased Sales but Faces Financial Challenges in 2025
5M ago
Cinclus Pharma Appoints 2026 AGM Nomination Committee
PremiumCompany Announcements
Cinclus Pharma Appoints 2026 AGM Nomination Committee
6M ago
Cinclus Pharma Holding AB: Promising Growth Potential with Linaprazan Glurate and Strategic Partnerships
PremiumRatingsCinclus Pharma Holding AB: Promising Growth Potential with Linaprazan Glurate and Strategic Partnerships
6M ago
Cinclus Pharma Highlights Need for New GERD Treatments at ISPOR Conference
Premium
Company Announcements
Cinclus Pharma Highlights Need for New GERD Treatments at ISPOR Conference
6M ago
Cinclus Pharma to Release Q3 2025 Financial Report
Premium
Company Announcements
Cinclus Pharma to Release Q3 2025 Financial Report
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >